Insurtech Investors: Compare Venture Funds and Sector Fit

An insurtech investor shortlist should start with the business you are financing: software sold to insurers, an insurance distribution business, or a company carrying underwriting risk. Those are different investment cases. This guide compares 16 specialist investors and gives you a practical way to separate sector interest from actual round fit.

A venture fund that understands insurance software is not automatically a source of underwriting capacity, a carrier partnership or regulatory approval. Keep the equity conversation separate from the commercial and risk-bearing relationships your business needs.

Compare the research starting points

Selection method: each entry has a first-party mandate, product page or identified primary transaction source supporting its relevance. This is a curated research map, not an exhaustive ranking or a statement that the firms are accepting every type of opportunity. Availability, check size and fit require current confirmation.

Read the mandate before requesting an introduction

MTech Capital

Its current thesis includes AI applied to customer experience and employee productivity. A useful approach explains the insurance workflow, the paying buyer and the evidence that the product changes that workflow.

Question to resolve: Does your company need software expertise, insurance distribution relationships, or both?

Source: MTech Capital

IA Capital Group

The firm lists property and casualty, life and health, and financial infrastructure among its interests. Match the specific business line rather than sending a generic insurance pitch.

Question to resolve: Is the target vehicle a fit for your geography and financing stage?

Source: IA Capital Group

Eos Ventures

The stated sector lens includes insurance alongside cybersecurity, longevity, wealth and payments. This makes it a useful research candidate for a company whose insurance relevance is clear but whose product crosses category boundaries.

Question to resolve: Is your company ready for a Series A lead conversation rather than an idea-stage introduction?

Source: Eos Ventures

Mundi Ventures, Insurtech Funds

Mundi describes a core insurance lens with adjacent financial, health, cyber and climate interests. Identify the relevant fund and market; do not treat its different regional strategies as one interchangeable mandate.

Question to resolve: Which vehicle and partner cover your market and use case?

Source: Mundi Ventures, Insurtech Funds

Brewer Lane Ventures

The firm describes a focus on how risk is assessed, financial services are delivered and infrastructure supports incumbents and startups. Its website supports sector relevance, not a universal check size or stage promise.

Question to resolve: What evidence connects your customer problem to its financial-services thesis?

Source: Brewer Lane Ventures

astorya.vc

Read the present resilience and security thesis rather than relying on an older insurtech-only description. A strong fit note identifies the specific risk or protection gap the company addresses.

Question to resolve: Does your European business fit the current thesis, not just an old portfolio label?

Source: astorya.vc

ManchesterStory

ManchesterStory describes early-stage investment backed by insurance and healthcare relationships. Explain the insurance buyer and deployment evidence; industry access should not be treated as a carrier agreement or a guaranteed customer.

Question to resolve: Which insurance workflow and paying customer support the investment case?

Source: ManchesterStory

FinTLV Ventures

FinTLV combines an insurance and financial-services thesis with a strategic industry network. Its portfolio shows insurance relevance, but founders should verify current round, market and vehicle fit rather than assume that sector interest implies idea-stage funding.

Question to resolve: What commercial evidence makes your model sufficiently proven for this team?

Source: FinTLV Ventures

Aquiline Venture

Aquiline lists insurance technology and services within its Venture portfolio. Distinguish that minority-equity strategy from its private-equity and credit offerings, and explain recurring revenue using a definition the investment team can reconcile.

Question to resolve: Does the company fit the Venture strategy rather than another Aquiline capital product?

Source: Aquiline Venture

InsurTech Fund, InsurTech NY

The InsurTech Fund describes investment in actionable insurance innovations. Use the fund mandate for the capital conversation, not participation in an InsurTech NY event or program as evidence of funding approval.

Question to resolve: Which insurance problem is already actionable, and what does the next round demonstrate?

Source: InsurTech Fund, InsurTech NY

American Family Ventures

American Family Ventures describes a multi-limited-partner model with a carrier perspective. Its scope includes insurance product lines, adjacent markets and enabling technology. Explain whether the product changes carrier operations, distribution or a customer experience, and bring evidence from the buyer who would adopt it.

Question to resolve: Which insurance buyer can validate the operational benefit?

Source: American Family Ventures

MS&AD Ventures

MS&AD Ventures presents a global, partnership-oriented investment approach and identifies insurtech among its focus areas. Separate the company-equity request from any proposed relationship with an insurance operating business. Establish which market, team and current investment process are relevant before relying on group reach.

Question to resolve: What can the investment team evaluate independently of a carrier partnership?

Source: MS&AD Ventures

Altai Ventures

Altai combines backing founders with building early-stage financial-services businesses. Frame the insurance use case precisely and clarify whether you seek investment in an existing company or a venture-building relationship. Those paths can involve different ownership and operating discussions.

Question to resolve: Is the request for an existing-company round or a company-building partnership?

Source: Altai Ventures

SURE Ventures

SURE includes insurance alongside aging, care, mental health and wealth management. The strongest fit brief explains the specific protection or risk problem, the customer and the evidence available at this early stage. Broader wellbeing relevance alone is not a substitute for a commercial model.

Question to resolve: What does the first institutional round prove about customer demand?

Source: SURE Ventures

Insurtech Gateway

Gateway describes institutional funds, incubators and an angel network as distinct parts of its model. This can suit founders who need insurance-specific venture-building support as well as capital. Confirm the relevant route and its terms; incubation support is not regulatory approval for the company.

Question to resolve: Which route fits: incubation, institutional investment or the angel network?

Source: Insurtech Gateway

Portage Ventures

Portage provides concrete insurance examples across underwriting, distribution and protection products. Use them to identify the right investment team and possible portfolio conflicts. Confirm the venture strategy rather than treating Portage Capital Solutions and all other platform offerings as the same round-financing route.

Question to resolve: Which venture team and insurance business model fit your round?

Source: Portage Ventures

Build the insurance-business fit map

Keep one row per candidate with the source URL, date checked, fit rationale, unresolved question, contact owner and next action. “Unknown” is a useful research status. Do not turn a portfolio example or a mutual connection into an assumed current mandate, available capital or permission to contact someone.

Worked example: a better first brief

Illustrative example: an early-stage claims-workflow software company has two paid insurer pilots but does not carry insurance risk. Its brief should show deployment time, the claims team using the product, the measured workflow change and the remaining procurement steps. It should not present gross written premium as its own revenue. An MGA would need a different brief explaining distribution, underwriting and capacity dependencies.

Questions to settle before outreach

• Who buys the product, who uses it and who bears the risk?
• Which evidence can you share without disclosing policyholder information?
• Would this investor be evaluating a software company, a distributor or a risk-bearing business?

Keep research connected to the next conversation

Use Finta to keep the relevant people, company context, source references and next action together. Ask Aurora to prepare a fit brief from the materials you provide or the authorized context available in your workspace. Review every factual assertion and the intended recipient before sending. Finta is not a promise of proprietary investor access, funding or transaction execution.

Try it with Aurora, Claude or Codex

Copy this prompt and add only material you are authorized to use. In Aurora, use the context available in your Finta workspace. Other assistants need the relevant inputs supplied separately.

Prepare a source-linked fit brief for the capital routes in this guide.
Our business and financing objective: [add a factual summary].
Use only the mandate pages and authorized materials I provide.
Compare: Business model; Commercial proof; Risk dependencies; Round fit.
For every candidate, separate verified fit, unknowns, possible conflicts and one question to confirm.
Return a short research register and a draft next step.
Do not invent check sizes, investor interest, introductions or advice about transaction suitability.

Review the result against the original sources before acting. A generated draft is not an approval or a completed external action.

Sources and freshness

Mandates and primary sources reviewed October 28, 2026. Firm descriptions above cite their evidence individually. Suggested fit questions and worked examples are editorial analysis, not statements by the investors. Recheck the current team, vehicle, process and portfolio before outreach.

Related resources

• Build a sourced investor shortlist
• Review fundraising stages and next actions

Informational disclaimer

This content is for informational and educational purposes only and is not legal, tax, accounting, investment or other professional advice. We are not lawyers or accountants. Check with your attorney, accountant or other qualified adviser about your circumstances and any proposed transaction, disclosure or legal obligation.